Author:
Pan Tongtong,Li Ting,Shi Lu,Su Lihuang,Chen Yongping
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference72 articles.
1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes.;Younossi;Hepatology,2016
2. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.;Estes;J Hepatol,2018
3. Structural specificity of heparin binding in the fibroblast growth factor family of proteins.;Raman;Proc Natl Acad Sci U S A,2003
4. Fibroblast growth factor 19: potential modulation of hepatic metabolism for the treatment of non-alcoholic fatty liver disease.;Sciarrillo;Liver Int,2021
5. Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the fibroblast growth factor 21 locus.;Bayoumi;Adv Sci (Weinh),2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献